 | Travere Therapeutics, Inc. | |||
| NGM : TVTX || Location: United States | ||||
$5.21-0.24 (-4.4%) |
0.4 M | 5.12 - 5.41 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 11.802 M |
| March 28, 2024 | 10.602 M |
| March 15, 2024 | 10.072 M |
| Feb. 29, 2024 | 10.261 M |
| Feb. 15, 2024 | 9.761 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.30 | -1.03 | 20.65% |
| 09/30/2023 | -0.15 | -1.17 | -703.57% |
| 06/30/2023 | -1.16 | -1.13 | 2.89% |
| 03/31/2023 | -1.19 | -1.27 | -6.34% |
| 12/31/2022 | -1.10 | -1.03 | 6.01% |
TVTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 76.109M | Shares Float | 60.545M |
| Short Float | 11.802M | Market Cap | 414.79M |
| Institution ownership | 0.00% | Insider ownership | 0.652% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.07 | Forward EPS | -1.75 |